期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Mechanisms of Helicobacter pylori antibiotic resistance:An updated appraisal 被引量:10
1
作者 Vincenzo De Francesco Angelo Zullo +3 位作者 Cesare Hassan Floriana Giorgio rosa rosania Enzo Ierardi 《World Journal of Gastrointestinal Pathophysiology》 CAS 2011年第3期35-41,共7页
Helicobacter pylori(H. pylori) antibiotic resistance is the main factor affecting the efficacy of the current eradicating therapies. The aim of this editorial is to report on the recent information about the mechanism... Helicobacter pylori(H. pylori) antibiotic resistance is the main factor affecting the efficacy of the current eradicating therapies. The aim of this editorial is to report on the recent information about the mechanisms accounting for the resistance to the different antibiotics currently utilized in H. pylori eradicating treatments. Different mechanisms of resistance to clarithromycin,metronidazole,quinolones,amoxicillin and tetracycline are accurately detailed(point mutations,redox intracellular potential,pump efflux systems,membrane permeability) on the basis of the most recent data available from the literature. The next hope for the future is that by improving the knowledge of resistance mechanisms,the elaboration of rational and efficacious associations for the treatment of the infection will be possible. Another auspicious progress might be the possibility of a cheap,feasible and reliable laboratory test to predict the outcome of a therapeutic scheme. 展开更多
关键词 HELICOBACTER pylori CLARITHROMYCIN METRONIDAZOLE LEVOFLOXACIN AMOXICILLIN TETRACYCLINE Resistance Antibiotic Point mutation
下载PDF
From chronic liver disorders to hepatocellular carcinoma: Molecular and genetic pathways 被引量:3
2
作者 Enzo Ierardi rosa rosania +5 位作者 Mariangela Zotti Floriana Giorgio Simonetta Prencipe Nicola Della Valle Vincenzo De Francesco Carmine Panella 《World Journal of Gastrointestinal Oncology》 SCIE CAS 2010年第6期259-264,共6页
Hepatocarcinogenesis is a process attributed to progressive genomic changes that alter the hepatocellular phenotype producing cellular intermediates that evolve into hepatocellular carcinoma (HCC). During the preneopl... Hepatocarcinogenesis is a process attributed to progressive genomic changes that alter the hepatocellular phenotype producing cellular intermediates that evolve into hepatocellular carcinoma (HCC). During the preneoplastic phase, the liver is often the site of chronic hepatitis and/or cirrhosis, and these conditions induce liver regeneration with accelerated hepatocyte cycling in an organ that is otherwise proliferatively at rest. Hepatocyte regeneration is accelerated by upregulation of mitogenic pathways involving molecular and genetic mechanisms. Hepatic growth factors, inhibitors and triggers may also play a role. This process leads to the production of monoclonal populations of aberrant and dysplastic hepatocytes that have telomerase reexpression, microsatellite instability, and occasionally structural aberrations in genes and chromosomes. Development of dysplastic hepatocytes in foci and nodules and the emergence of HCC are associated with the accumulation of irreversible structural alterations in genes and chromosomes even if the genomic basis of the malignant phenotype is largely heterogeneous. Therefore, a malignant hepatocyte phenotype may be produced by changes in genes acting through different regulatory pathways, thus producing several molecular variants of HCC. On these bases, a key point for future research will be to determine whether the deletions are specific, due to particular loci in the minimally deleted regions of affected chromosome arms, or whether they are nonspecific with loss of large portions of chromosomes or entire chromosome arms leading to passive deletion of loci. The final aim is the possibility of identifying a step where carcinogenetic processes could be terminated. 展开更多
关键词 HEPATOCARCINOMA CHRONIC LIVER DISORDERS Genetic PATHWAYS MOLECULAR PATHWAYS Hepatic growth factors Augmenter LIVER regeneration
下载PDF
Metabolic syndrome and gastro-esophageal reflux:A link towards a growing interest in developed countries 被引量:1
3
作者 Enzo Ierardi rosa rosania +5 位作者 Mariangela Zotti Simonetta Principe Giulio Laonigro Floriana Giorgio Vincenzo de Francesco Carmine Panella 《World Journal of Gastrointestinal Pathophysiology》 CAS 2010年第3期91-96,共6页
The aim of this Editorial is to describe the growing possibility of a link between gastro-esophageal reflux disease (GERD) and metabolic syndrome on the light of recent epidemiological and pathophysiological evidence.... The aim of this Editorial is to describe the growing possibility of a link between gastro-esophageal reflux disease (GERD) and metabolic syndrome on the light of recent epidemiological and pathophysiological evidence. The state of the art of GERD is described,based on recent definitions,pathophysiological evidence,epidemiology in developed countries,clinical subtypes together with a diagnostic approach specifically focussed on the appropriateness of endoscopy. Metabolic syndrome is accurately defined and the pivotal role of insulin resistance is emphasized. The strong relationship between GERD and metabolic syndrome has been pathophysiologically analyzed,taking into account the role of obesity,mechanical factors and metabolic changes. Data collected by our group regarding eating habits and GERD are briefly summarized at the end of a pathophysiological analysis. The literature on the subject strongly supports the possibility that lifestyle and eating habits may be involved in both GERD and metabolic syndrome in developed countries. 展开更多
关键词 GASTROESOPHAGEAL REFLUX disease METABOLIC syndrome Obesity INSULIN resistance
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部